Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-068630

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO,Chief Scientist & Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Nov 13, 2017
Accepted (ET)
Nov 14, 2017 · 7:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 13, 2017M319,792$12.023D1,897,847D
Common StockF1Nov 13, 2017M186,545$12.023D1,263,378ISee footnote
Common StockF2holding———7,461,594ISee footnote
Common StockF3holding———5,000ISee footnote
Common StockF4holding———200,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$12.023Nov 13, 2017M319,792D—Jul 5, 2018Common Stock319,792959,375D
Employee Stock Option (right to buy)F1,F5$12.023Nov 13, 2017M186,545D—Jul 5, 2018Common Stock186,545559,636I

Explanation of responses